SINGAPORE, SG / ACCESS Newswire / September 28, 2026 / Immortal Dragons, the $40 million purpose-driven longevity fund, today announced its strategic investment in Renewal Bio, an Israeli regenerative medicine company developing patient-matched human cells for transplantation. Renewal Bio was…